Content area



Mai Christiansen Arlien-Søborg1, Anne Mohr Drewes1, Mogens Pfeiffer-Jensen2 & Jens Otto Lunde Jørgensen1
1) Klinik for Diabetes og Hormonsygdomme, Aarhus Universitetshospital 2) Reumatologisk Afdeling, Aarhus Universitetshospital

Ugeskr Læger 2018;180:V09170637
Ugeskr Læger 2018;180:V09170637
Blad nummer: 

Mai Christiansen Arlien-Søborg, Anne Mohr Drewes,
Mogens Pfeiffer-Jensen & Jens Otto Lunde Jørgensen:


Ugeskr Læger 2018;180:V09170637

Acromegaly is a rare and disabling disease with a plethora of symptoms and signs attributed to sustained elevations and actions of growth hormone and insulin-like growth factor 1. Acromegaly is characterised by excessive somatic growth and multiple comorbidities in addition to occasional compression of the optic nerve and hypopituitarism due to the underlying adenoma. The course of the disease is insidious, and a diagnostic delay of 5-10 years is typical, and this pre-diagnostic period is also associated with increased morbidity. Effective treatment is available, once the diagnosis is established.

Du skal være logget ind for at læse denne artikel
Log ind

Right side

af Adam Sinding | 03/07
4 kommentarer
af Helga Schultz | 01/07
2 kommentarer
af H-J Lundsgaard Sørensen | 27/06
1 Kommentar
af Per Fl. Nygaard Andresen | 25/06
27 kommentarer
af Erik Fink Eriksen | 24/06
1 Kommentar